Latest / Cleveland Clinic Cancer Advances
Beyond 7+3: Redefining AML Treatment with Targeted Therapies and Trials
Director of the Inpatient Leukemia Unit, Anjali Advani, MD joins the Cancer Advances podcast to break down the latest acute myeloid leukemia clinical trials. From venetoclax-based regimens to emerging menin inhibitors and mutation-driven strategies, listen as Dr. Advani explains how rapid genomics, novel combinations and evolving transplant decisions are reshaping AML care and what still lies ahead for high-risk disease.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.